Join the 200th Anniversary Celebration

Browse Glomerular Disease

Showing 1 to 20 of 281 Articles

Sort By:

  • Correspondence

    To the Editor: Recurrent primary focal segmental glomerulosclerosis (FSGS) develops in over 40% of renal-transplant recipients and presents a major therapeutic challenge. The first marker of disease recurrence is often proteinuria in the nephrotic range that can appear 2 to 3 days after…

    • April 26, 2012
    • N Engl J Med 2012; 366:1648-1649
    • Free Full Text

    The authors of this letter describe the successful retransplantation of an allograft that was failing in its first recipient owing to recurrent primary focal segmental glomerulosclerosis. In the second recipient, all evidence of the nephrotic syndrome resolved.

  • Correspondence

    To the Editor: Dense-deposit disease (also known as membranoproliferative glomerulonephritis type II) is a rare glomerulopathy characterized by electron-dense deposits in the glomerular basement membrane as well as the glomerular deposition of complement. Within 10 years, the disease progresses to…

    • March 22, 2012
    • N Engl J Med 2012; 366:1163-1165
    • Free Full Text

    Dysregulation of the alternative complement pathway plays a pathogenic role in dense-deposit disease (also known as membranoproliferative glomerulonephritis type II). This letter reports the use of eculizumab in a patient with this disease.

  • Review Article

    Membranoproliferative glomerulonephritis (MPGN), also termed mesangiocapillary glomerulonephritis, is diagnosed on the basis of a glomerular-injury pattern that is common to a heterogeneous group of diseases. MPGN accounts for approximately 7 to 10% of all cases of biopsy-confirmed…

    • March 22, 2012
    • Sethi S. and Fervenza F.C.
    • N Engl J Med 2012; 366:1119-1131
    • CME

    This review discusses the causes, pathogenesis, and clinical management of membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed glomerulonephritis cases. Current classification reflects advances in the understanding of this condition.

  • Correspondence

    To the Editor: Membranoproliferative glomerulonephritis (MPGN) mainly affects children, often progresses to end-stage kidney disease, and can recur after transplantation. Primary MPGN is one of several glomerulopathies that have recently been linked to dysregulation of the complement alternative…

    • March 22, 2012
    • N Engl J Med 2012; 366:1165-1166
    • Free Full Text

    This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic.

  • Correspondence

    To the Editor: In 1999, an 11-year-old girl with the nephrotic syndrome received a biopsy-confirmed diagnosis of membranoproliferative glomerulonephritis. The level of plasma complement C3 was 7 mg per deciliter (normal range, 90 to 180). Glucocorticoids, administered for 5 years, were ineffective.…

    • March 22, 2012
    • N Engl J Med 2012; 366:1161-1163
    • Free Full Text

    This letter indicates that in a patient with long-standing dense-deposit disease, a variant of membranoproliferative glomerulonephritis, eculizumab can be useful in the resolution of the nephrotic syndrome.

  • Original Article

    An impaired glomerular filtration rate (GFR) is the final common pathway of diabetic kidney disease. Once the GFR is impaired, cardiovascular disease events and progression to end-stage renal disease occur at unacceptably high rates, even with proven medical management.– This underscores the need…

    • December 22, 2011
    • The DCCT/EDIC Research Group
    • N Engl J Med 2011; 365:2366-2376
    • CME

    Persons with type 1 diabetes are at high risk for kidney disease. In this study, intensive diabetes therapy administered early in the course of type 1 diabetes reduced the long-term risk of an impaired glomerular filtration rate.

  • Review Article

    Focal segmental glomerulosclerosis accounts for approximately 20% of cases of the nephrotic syndrome in children and 40% of such cases in adults, with an estimated incidence of 7 per 1 million. It is the most common primary glomerular disorder causing end-stage renal disease in the United States,…

    • December 22, 2011
    • D'Agati V.D., Kaskel F.J., Falk R.J.
    • N Engl J Med 2011; 365:2398-2411
    • CME

    Focal segmental glomerulosclerosis, which is characterized by progressive glomerular scarring, accounts for about 20% of cases of the nephrotic syndrome in children and 40% in adults. This review considers current approaches to diagnosis and management of the disease.

  • Original Article

    Charcot–Marie–Tooth disease refers to a heterogeneous group of inherited chronic peripheral motor and sensory neuropathies. Affected persons typically present with progressive distal-muscle weakness and atrophy, reduced tendon reflexes, and foot and hand deformities. Three…

    • December 22, 2011
    • Boyer O., Nevo F., Plaisier E., et al.
    • N Engl J Med 2011; 365:2377-2388

      The authors report that INF2 mutations are present in patients with focal segmental glomerulosclerosis (FSGS) associated with Charcot–Marie–Tooth neuropathy. The findings provide insight into mechanisms linking formin proteins to podocyte and Schwann-cell function.

    • Correspondence

      To the Editor: Membranoproliferative glomerulonephritis (MPGN) type II (MPGN II), also called dense-deposit disease, is a rare glomerular disease that often progresses to end-stage renal disease. MPGN II is associated with complement because of systemic C3 activation and deposition of C3 cleavage…

      • December 15, 2011
      • N Engl J Med 2011; 365:2340-2342
      • Free Full Text

      This letter describes two unrelated patients with membranoproliferative glomerulonephritis type 2 and autoantibodies to the two individual components of C3 convertase, factor B and C3. These autoantibodies enhance C3 convertase activity, probably leading to nephritis.

    • Editorial

      Focal segmental glomerulosclerosis, one of the most common glomerulopathies, is typically heralded by massive proteinuria, often associated with unremitting nephrotic syndrome and inexorable progression to end-stage kidney disease.– Unfortunately, therapy is frequently unsuccessful — many…

      • July 28, 2011
      • Ingelfinger J.R.
      • N Engl J Med 2011; 365:368-369

        Focal segmental glomerulosclerosis, one of the most common glomerulopathies, is typically heralded by massive proteinuria, often associated with unremitting nephrotic syndrome and inexorable progression to end-stage kidney disease.13 Unfortunately, ...

      • Original Article

        Focal segmental glomerulosclerosis is a kidney lesion characterized by glomerulosclerosis that is focal (involving a subgroup of glomeruli) and segmental (involving a portion of the glomerular tuft). As the disease progresses, the pattern of glomerulosclerosis becomes predominantly global.…

        • July 28, 2011
        • Mele C., Iatropoulos P., Donadelli R., et al.
        • N Engl J Med 2011; 365:295-306
        • Free Full Text
        • Video

        Focal segmental glomerulosclerosis (FSGS) affects the podocytes. The molecular cause of over half the cases is unknown, and treatment is elusive. This study identifies two mutations in MYO1E, which encodes the nonmuscle class I myosin.

      • Original Article

        Membranous nephropathy has an incidence of approximately 1 case per 100,000 persons per year, and its phenotype has been clearly defined on the basis of histologic features, making it a good subject for genomewide association studies. Recognized as a clinicopathological entity in the 1950s,…

        • February 17, 2011
        • Stanescu H.C., Arcos-Burgos M., Medlar A., et al.
        • N Engl J Med 2011; 364:616-626
        • Free Full Text

        Independent genomewide association studies were carried out to investigate the genetic basis of idiopathic membranous nephropathy in three groups of white patients. An HLA–DQA1 allele on chromosome 6p21 was found to be significantly associated with this disease.

      • Editorial

        The rapid evolution of array techniques and the completion of the map of the human genome have led to a host of genomewide association studies over the past few years. Yet many of these studies have been disappointing; they identify genes that confer only a moderate increase in risk and explain…

        • February 17, 2011
        • Segelmark M.
        • N Engl J Med 2011; 364:679-680

          The rapid evolution of array techniques and the completion of the map of the human genome have led to a host of genomewide association studies over the past few years. Yet many of these studies have been disappointing; they identify genes that confer only ...

        • Correspondence

          To the Editor: Membranous nephropathy is a common cause of the nephrotic syndrome in adults. Treatment is controversial and challenging because of the heterogeneity of the disease and a lack of reliable biomarkers. M-type phospholipase A2 receptor (PLA2R) was recently identified as a major target…

          • February 17, 2011
          • N Engl J Med 2011; 364:689-690
          • Free Full Text

          To the Editor: Membranous nephropathy is a common cause of the nephrotic syndrome in adults. Treatment is controversial and challenging because of the heterogeneity of the disease and a lack of reliable biomarkers.1,2 M-type phospholipase A2 receptor (...

        • Clinical Implications of Basic Research

          Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease that predominantly affects the kidneys in the form of lupus nephritis, although multiple organs can be involved. Lupus nephritis is characterized by the deposition in glomeruli of immune complexes formed by IgG, IgM, and…

          • September 9, 2010
          • Kaveri S.V., Mouthon L., Bayry J.
          • N Engl J Med 2010; 363:1080-1082

            Activated basophils in the circulation, lymph nodes, and spleen may augment the risk of nephritis in systemic lupus erythematosus.

          • Editorial

            In this issue of the Journal, Pedchenko et al. increase our understanding of the pathogenesis of two forms of antibody-mediated glomerulonephritis. One, Goodpasture's disease, is an organ-specific autoimmune disease that is mediated by anti–glomerular basement membrane (anti-GBM) antibodies and…

            • July 22, 2010
            • Salant D.J.
            • N Engl J Med 2010; 363:388-391

              In this issue of the Journal, Pedchenko et al.1 increase our understanding of the pathogenesis of two forms of antibody-mediated glomerulonephritis. One, Goodpasture's disease, is an organ-specific autoimmune disease that is mediated by anti–glomerular ...

            • Original Article

              Goodpasture's disease is an organ-specific autoimmune disorder characterized by rapidly progressive glomerulonephritis, pulmonary hemorrhage, and glomerular pathological findings that include linear deposits of antibodies along the glomerular basement membrane (GBM) (Figure 1A). (For this article…

              • July 22, 2010
              • Pedchenko V., Bondar O., Fogo A.B., et al.
              • N Engl J Med 2010; 363:343-354
              • Free Full Text

              This study compared the conformation of the antibody epitopes in Goodpasture's disease and Alport's post-transplantation nephritis in search of the pathogenesis of anti–basement membrane glomerulonephritis. The authors report evidence that the initiation of such disease depends on the conformation involving perturbation of the quaternary structure of basement-membrane collagen, eliciting an autoimmune response.

            • Clinical Problem-Solving

              Foreword. In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows. Stage. A 62-year-old, generally healthy…

              • April 1, 2010
              • Marinopoulos S.S., Coylewright M., Auwaerter P.G., Flynn J.A.
              • N Engl J Med 2010; 362:1228-1233

                A 62-year-old, generally healthy man presented with a “clogged” sensation and a 6-week history of diminished hearing in his right ear. He had no tinnitus, ear pain, or dizziness.

              • Case Records of the Massachusetts General Hospital

                Presentation of Case. A 51-year-old man with a history of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection was seen in the nephrology clinic of this hospital because of proteinuria, edema, and hypertension. The patient had been in his usual state of health until…

                • February 18, 2010
                • Radhakrishnan J., Uppot R.N., Colvin R.B.
                • N Engl J Med 2010; 362:636-646

                  A 51-year-old man with human immunodeficiency virus and hepatitis C virus infections presented with proteinuria, edema, and worsening hypertension. He had obesity, hyperlipidemia, obstructive sleep apnea, and a history of hypertension and coronary artery disease. He had recently taken nonsteroidal antiinflammatory drugs for joint pain. A diagnostic procedure was performed.

                • Original Article

                  Idiopathic membranous nephropathy, a common cause of the nephrotic syndrome in adults, is an organ-specific autoimmune disease. Despite extensive investigation, a target antigen has been elusive. Studies of membranous nephropathy in a rat model (Heymann's nephritis) established that the…

                  • July 2, 2009
                  • Beck L.H., Bonegio R.G.B., Lambeau G., et al.
                  • N Engl J Med 2009; 361:11-21
                  • Free Full Text

                  In this study of patients with membranous nephropathy, serum samples from 70% of patients with idiopathic, but not secondary, membranous nephropathy were found to have antibodies against a 185-kD glycoprotein in nonreduced glomerular extracts, identified as the M-type phospholipase A2 receptor (PLA2R). PLA2R is present in normal podocytes and in immune deposits in patients with idiopathic membranous nephropathy, indicating that PLA2R is a major antigen in this disease.

                Page

                Medical Meetings Pediatrics Conferences and Meetings

                2012 Certifying Examinations of the American Board of Pediatrics

                The general pediatrics examination will be held in various cities, Oct. 16-18. Registration for first-time applicants is ongoing through May 3. Registration for re-registrants is ongoing through May 24. The following subspecialty examinations will be held in various cities: "Hospice and Palliative Medicine" (Oct. 4); "Pediatric Transplant Hepatology" (Oct. 11); "Pediatric Cardiology" (Nov. 7); "Pediatric Pulmonology" (Nov. 8); "Medical Toxicology" (Nov. 12); and "Pediatric Critical Care Medicine" (Nov. 14). Registration for first-time applicants is ongoing through April 30. Registration for re-registrants is ongoing through June 15.

                Contact the American Board of Pediatrics, 111 Silver Cedar Court, Chapel Hill, NC 27514-1513; or call (919) 929-0461; or fax (919) 918-7114 or (919) 929-9255; or see http://www.abp.org .

                More Medical Meetings